1995 growth of pacemaker market estimated at 13%
This article was originally published in Clinica
US broker Morgan Stanley forecasts sustainable growth for the worldwide pacemaker market in the high single-digit range after a strong 1995 rise of around 13%. Analyst Glenn Reicin estimates the 1995 pacemaker market, one of the largest markets in medical technology, at $2,300 million, half of which are US sales.
You may also be interested in...
The European public assessment report for Kaftrio shows that EU regulators had concerns about whether Vertex’s triple drug combination for cystic fibrosis represented a new treatment paradigm.
Swissmedic says its good manufacturing practice certificates remain valid for longer than companies might assume. Separately, it is giving companies more time to conduct nitrosamine-related risk evaluations.
Stada has appointed a head of digital communications; PGEU elects new chair and vice-chair; and the new UK health claims committee unveils its first members.